Global Glycerophosphorylcholine (GPC) Supply, Demand and Key Producers, 2026-2032

The global Glycerophosphorylcholine (GPC) market size is expected to reach $ 113 million by 2032, rising at a market growth of 5.5% CAGR during the forecast period (2026-2032).

L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer"s disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.

Global key players of Glycerophosphorylcholine (GPC) include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co and Suzhou Fushilai Pharmaceutical, etc. Global top four manufacturers hold a share over 50%. China is the largest producer of Glycerophosphorylcholine (GPC), followed by Europe.

This report studies the global Glycerophosphorylcholine (GPC) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Glycerophosphorylcholine (GPC) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Glycerophosphorylcholine (GPC) that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Glycerophosphorylcholine (GPC) total production and demand, 2021-2032, (MT)

Global Glycerophosphorylcholine (GPC) total production value, 2021-2032, (USD Million)

Global Glycerophosphorylcholine (GPC) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)

Global Glycerophosphorylcholine (GPC) consumption by region & country, CAGR, 2021-2032 & (MT)

U.S. VS China: Glycerophosphorylcholine (GPC) domestic production, consumption, key domestic manufacturers and share

Global Glycerophosphorylcholine (GPC) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)

Global Glycerophosphorylcholine (GPC) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)

Global Glycerophosphorylcholine (GPC) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)

This report profiles key players in the global Glycerophosphorylcholine (GPC) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Glycerophosphorylcholine (GPC) market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Glycerophosphorylcholine (GPC) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Glycerophosphorylcholine (GPC) Market, Segmentation by Type:
Liquid Glycerophosphorylcholine
Powder Glycerophosphorylcholine

Global Glycerophosphorylcholine (GPC) Market, Segmentation by Application:
Pharmaceutical
Health Products

Companies Profiled:
Lipoid GmbH
Archimica SpA
Jiangsu Weiqida Pharmaceutical Co
Suzhou Fushilai Pharmaceutical
Foman Biopharma
JYOUKI Pharmaceutical Co
Wuxi Cima Science Co
Changsha Jiaxi Biotechnology

Key Questions Answered:

1. How big is the global Glycerophosphorylcholine (GPC) market?

2. What is the demand of the global Glycerophosphorylcholine (GPC) market?

3. What is the year over year growth of the global Glycerophosphorylcholine (GPC) market?

4. What is the production and production value of the global Glycerophosphorylcholine (GPC) market?

5. Who are the key producers in the global Glycerophosphorylcholine (GPC) market?

6. What are the growth factors driving the market demand? Show more